Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018

Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018–2019

Published:2022-01 Issue:1 Volume:28 Page:52-62
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Kracalik Ian,Ham D. Cal,McAllister Gillian,Smith Amanda R.,Vowles Maureen,Kauber Kelly,Zambrano Melba,Rodriguez Gretchen,Garner Kelley,Chorbi Kaitlyn,Cassidy P. Maureen,McBee Shannon,Stoney Rhett J.,Moser Kathleen,Villarino Margarita E.,Zazueta Oscar E.,Bhatnagar Amelia,Sula Erisa,Stanton Richard A.,Brown Allison C.,Halpin Alison L.,Epstein Lauren,Walters Maroya Spalding,

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference40 articles.

1. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.;Weiner-Lastinger;Infect Control Hosp Epidemiol,2020

2. Carbapenem-resistant Pseudomonas aeruginosa at US emerging infections program sites, 2015.;Walters;Emerg Infect Dis,2019

3. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms—United States, 2006‒2017.;Woodworth;MMWR Morb Mortal Wkly Rep,2018

4. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.;Edelstein;Lancet Infect Dis,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracing the origin of NDM-1-producing and extensively drug-resistant Pseudomonas aeruginosa ST357 in the Netherlands;BMC Infectious Diseases;2024-08-13

2. Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears;Clinical Infectious Diseases;2024-02-05

3. In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity;Journal of Antimicrobial Chemotherapy;2023-12-28

4. Unexpected Hazards, Unanticipated Risks;Emerging Infectious Diseases;2023-08

5. Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia;Heliyon;2023-05